Role of Ca2+/calmodulin-dependent kinase II-IRAK1 interaction in LMP1-induced NF-ΚB activation

Molecular and Cellular Biology

Volumn 34, Issue 3, 2014, Pages 325-334

  Kim, Jung Eun ^a   Kim, Sang Yong ^a   Lim, Sue Yeon ^a   Kieff, Elliott ^b   Song, Yoon Jae ^a  

^a Gachon University   (South Korea)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; LATENT MEMBRANE PROTEIN 1; TRANSCRIPTION FACTOR RELA; EBV ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN BARR VIRUS; EBV-ASSOCIATED MEMBRANE ANTIGEN, EPSTEIN-BARR VIRUS; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; IRAK1 PROTEIN, MOUSE; MATRIX PROTEIN; SERINE;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; ANIMAL; ANIMAL EMBRYO; CELL CULTURE; CELL STRAIN HEK293; CYTOLOGY; ENZYME ACTIVATION; FIBROBLAST; GENETICS; HUMAN; KNOCKOUT MOUSE; METABOLISM; MUTATION; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELLS, CULTURED; EMBRYO, MAMMALIAN; ENZYME ACTIVATION; FIBROBLASTS; HEK293 CELLS; HUMANS; INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES; MICE; MICE, KNOCKOUT; MUTATION; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; RNA INTERFERENCE; SERINE; TRANSCRIPTION FACTOR RELA; VIRAL MATRIX PROTEINS;

EID: 84892453744     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00912-13     Document Type: Article

References (58)

1. p65/RelA serine 536 phosphorylation and NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 103:2689-2694. http://dx.doi.org/10.1073/pnas.0511096103.
2. Kieff ED, Rickinson AB. 2007. Epstein-Barr virus and its replication, p 2603-2655. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 2. Lippincott, Williams, and Wilkins, Philadelphia, PA.
3. Mitchell T, Sugden B. 1995. Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968-2976.
4. Huen DS, Henderson SA, Croom-Carter D, Rowe M. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NFkappa B and cell surface phenotype via two effector regions in its carboxyterminal cytoplasmic domain. Oncogene 10:549-560.
5. Devergne O, Cahir McFarland ED, Mosialos G, Izumi KM, Ware CF, Kieff E. 1998. Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J. Virol. 72:7900-7908.
6. Devergne O, Hatzivassiliou E, Izumi KM, Kaye KM, Kleijnen MF, Kieff E, Mosialos G. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol. Cell. Biol. 16:7098-7108.
7. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399. http://dx.doi.org/10.1016/0092-8674(95)90489-1.
8. Kaye KM, Devergne O, Harada JN, Izumi KM, Yalamanchili R, Kieff E, Mosialos G. 1996. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. U. S. A. 93:11085-11090. http://dx.doi.org/10.1073/pnas.93.20.11085.
9. Kaye KM, Izumi KM, Mosialos G, Kieff E. 1995. The Epstein-Barr virus LMP1 cytoplasmic carboxy terminus is essential for B-lymphocyte transformation; fibroblast cocultivation complements a critical function within the terminal 155 residues. J. Virol. 69:675-683.
10. Izumi KM, Cahir McFarland ED, Riley EA, Rizzo D, Chen Y, Kieff E. 1999. The residues between the two transformation effector sites of Ep-stein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation. J. Virol. 73:9908-9916.
11. Cahir-McFarland ED, Carter K, Rosenwald A, Giltnane JM, Henrickson SE, Staudt LM, Kieff E. 2004. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells. J. Virol. 78:4108-4119. http://dx.doi.org/10.1128/JVI.78.8.4108-4119.2004.
12. Cahir-McFarland ED, Davidson DM, Schauer SL, Duong J, Kieff E. 2000. NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. U. S. A. 97:6055-6060. http://dx.doi.org/10.1073/pnas.100119497.
13. Ghosh S, Karin M. 2002. Missing pieces in the NF-kappaB puzzle. Cell 109(Suppl):S81-S96. http://dx.doi.org/10.1016/S0092-8674(02)00703-1.
14. Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev. 18: 2195-2224. http://dx.doi.org/10.1101/gad.1228704.
15. Bonizzi G, Karin M. 2004. The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280- 288. http://dx.doi.org/10.1016/j.it.2004.03.008.
16. Izumi KM, Cahir McFarland ED, Ting AT, Riley EA, Seed B, Kieff ED. 1999. The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation. Mol. Cell. Biol. 19:5759-5767.
17. Izumi KM, Kaye KM, Kieff ED. 1997. The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc. Natl. Acad. Sci. U. S. A. 94:1447-1452. http://dx.doi.org/10.1073/pnas.94.4.1447.
18. Izumi KM, Kieff ED. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptorassociated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc. Natl. Acad. Sci. U. S. A. 94: 12592-12597. http://dx.doi.org/10.1073/pnas.94.23.12592.
19. Song YJ, Izumi KM, Shinners NP, Gewurz BE, Kieff E. 2008. IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3. Proc. Natl. Acad. Sci. U. S. A. 105:18448-18453. http://dx.doi.org/10.1073/pnas.0809933105.
20. Gottipati S, Rao NL, Fung-Leung WP. 2008. IRAK1: a critical signaling mediator of innate immunity. Cell. Signal. 20:269-276. http://dx.doi.org/10.1016/j.cellsig.2007.08.009.
21. Janssens S, Beyaert R. 2003. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11:293-302. http://dx.doi.org/10.1016/S1097-2765(03)00053-4.
22. Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X. 2002. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol. Cell. Biol. 22:7158-7167. http://dx.doi.org/10.1128/MCB.22.20.7158-7167.2002.
23. Handoyo H, Stafford MJ, McManus E, Baltzis D, Peggie M, Cohen P. 2009. IRAK1-independent pathways required for the interleukin-1-stimulated activation of the Tpl2 catalytic subunit and its dissociation from ABIN2. Biochem. J. 424:109-118. http://dx.doi.org/10.1042/BJ20091271.
24. Kawagoe T, Sato S, Matsushita K, Kato H, Matsui K, Kumagai Y, Saitoh T, Kawai T, Takeuchi O, Akira S. 2008. Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. Nat. Immunol. 9:684-691. http://dx.doi.org/10.1038/ni.1606.
25. Kim TW, Yu M, Zhou H, Cui W, Wang J, DiCorleto P, Fox P, Xiao H, Li X. 2012. Pellino 2 is critical for Toll-like receptor/interleukin-1 receptor (TLR/IL-1R)-mediated post-transcriptional control. J. Biol. Chem. 287: 25686-25695. http://dx.doi.org/10.1074/jbc.M112.352625.
26. Kim YI, Park JE, Martinez-Hernandez A, Yi AK. 2008. CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases. J. Biol. Chem. 283:15258- 15270. http://dx.doi.org/10.1074/jbc.M709549200.
27. Thomas JA, Haudek SB, Koroglu T, Tsen MF, Bryant DD, White DJ, Kusewitt DF, Horton JW, Giroir BP. 2003. IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction. Am. J. Physiol. Heart Circ. Physiol. 285:H597-H606. http://dx.doi.org/10.1152/ajpheart.0655.2001.
28. Windheim M, Stafford M, Peggie M, Cohen P. 2008. Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptorassociated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase. Mol. Cell. Biol. 28:1783-1791. http://dx.doi.org/10.1128/MCB.02380-06.
29. Conze DB, Wu CJ, Thomas JA, Landstrom A, Ashwell JD. 2008. Lys63-linked polyubiquitination of IRAK-1 is required for interleukin-1 receptor- and toll-like receptor-mediated NF-kappaB activation. Mol. Cell. Biol. 28:3538-3547. http://dx.doi.org/10.1128/MCB.02098-07.
30. Swantek JL, Tsen MF, Cobb MH, Thomas JA. 2000. IL-1 receptorassociated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:4301-4306. http://www.jimmunol.org/content/164/8/4301.
31. Liu G, Park YJ, Abraham E. 2008. Interleukin-1 receptor-associated kinase (IRAK)-1-mediated NF-kappaB activation requires cytosolic and nuclear activity. FASEB J. 22:2285-2296. http://dx.doi.org/10.1096/fj.07 -101816.
32. Huang Y, Li T, Sane DC, Li L. 2004. IRAK1 serves as a novel regulator essential for lipopolysaccharide-induced interleukin-10 gene expression. J. Biol. Chem. 279:51697-51703. http://dx.doi.org/10.1074/jbc.M410369200.
33. Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E. 2003. Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6. Proc. Natl. Acad. Sci. U. S. A. 100: 15595-15600. http://dx.doi.org/10.1073/pnas.2136756100.
34. Kim JE, Jun S, Song M, Kim JH, Song YJ. 2012. The extract of Chrysanthemum indicum Linne inhibits EBV LMP1-induced NF-kappaB activation and the viability of EBV-transformed lymphoblastoid cell lines. Food Chem. Toxicol. 50:1524-1528. http://dx.doi.org/10.1016/j.fct.2012.02.034.
35. Bari W, Song YJ, Yoon SS. 2011. Suppressed induction of proinflammatory cytokines by a unique metabolite produced by Vibrio cholerae O1 El Tor biotype in cultured host cells. Infect. Immun. 79:3149-3158. http://dx.doi.org/10.1128/IAI.01237-10.
36. Rosendorff A, Sakakibara S, Lu S, Kieff E, Xuan Y, DiBacco A, Shi Y, Gill G. 2006. NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression. Proc. Natl. Acad. Sci. U. S. A. 103: 5308-5313. http://dx.doi.org/10.1073/pnas.0601066103.
37. Tombes RM, Faison MO, Turbeville JM. 2003. Organization and evolution of multifunctional Ca(2)/CaM-dependent protein kinase genes. Gene 322:17-31. http://dx.doi.org/10.1016/j.gene.2003.08.023.
38. Heist EK, Srinivasan M, Schulman H. 1998. Phosphorylation at the nuclear localization signal of Ca2/calmodulin-dependent protein kinase II blocks its nuclear targeting. J. Biol. Chem. 273:19763-19771. http://dx.doi.org/10.1074/jbc.273.31.19763.
39. Chen LF, Greene WC. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5:392-401. http://dx.doi.org/10.1038/nrm1368.
40. Smale ST. 2011. Hierarchies of NF-kappaB target-gene regulation. Nat. Immunol. 12:689-694. http://dx.doi.org/10.1038/ni.2070.
41. Viatour P, Merville MP, Bours V, Chariot A. 2005. Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30:43-52. http://dx.doi.org/10.1016/j.tibs.2004.11.009.
42. p65 to TATA-binding protein-associated factor II31-mediated interleukin-8 transcription. J. Biol. Chem. 279:55633-55643. http://dx.doi.org/10.1074/jbc.M409825200.
43. Fujita F, Taniguchi Y, Kato T, Narita Y, Furuya A, Ogawa T, Sakurai H, Joh T, Itoh M, Delhase M, Karin M, Nakanishi M. 2003. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol. Cell. Biol. 23:7780-7793. http://dx .doi.org/10.1128/MCB.23.21.7780-7793.2003.
44. p65 Subunit of NF-kappa B through utilization of the Ikappa B kinase and activation of the mitogenactivated protein kinase p38. J. Biol. Chem. 276:18934-18940. http://dx.doi.org/10.1074/jbc.M101103200.
45. p65/RelA subunit. Mol. Cell. Biol. 19:4798-4805.
46. p65 at serine 536. J. Biol. Chem. 278:919-926. http://dx.doi.org/10.1074/jbc.M208696200.
47. p65 phosphorylation and TNF-induced nuclear translocation of IKK epsilon. Nucleic Acids Res. 38:6029-6044. http://dx.doi.org/10.1093/nar/gkq439
48. Braun AP, Schulman H. 1995. The multifunctional calcium/calmodulindependent protein kinase: from form to function. Annu. Rev. Physiol. 57:417-445. http://dx.doi.org/10.1146/annurev.ph.57.030195.002221.
49. Ishiguro K, Ando T, Goto H, Xavier R. 2007. Bcl10 is phosphorylated on Ser138 by Ca2+/calmodulin-dependent protein kinase II. Mol. Immunol. 44:2095-2100. http://dx.doi.org/10.1016/j.molimm.2006.09.012
50. Ishiguro K, Green T, Rapley J, Wachtel H, Giallourakis C, Landry A, Cao Z, Lu N, Takafumi A, Goto H, Daly MJ, Xavier RJ. 2006. Ca2+/ calmodulin-dependent protein kinase II is a modulator of CARMA1-mediated NF-kappaB activation. Mol. Cell. Biol. 26:5497-5508. http://dx .doi.org/10.1128/MCB.02469-05.
51. Liu X, Yao M, Li N, Wang C, Zheng Y, Cao X. 2008. CaMKII promotes TLR-triggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 112:4961-4970. http://dx.doi.org/10.1182/blood-2008-03-144022
52. Dellis O, Arbabian A, Papp B, Rowe M, Joab I, Chomienne C. 2011. Epstein-Barr virus latent membrane protein 1 increases calcium influx through store-operated channels in B lymphoid cells. J. Biol. Chem. 286: 18583-18592. http://dx.doi.org/10.1074/jbc.M111.222257
53. Caran N, Johnson LD, Jenkins KJ, Tombes RM. 2001. Cytosolic targeting domains ofgammaand delta calmodulin-dependent protein kinase II. J. Biol. Chem. 276:42514-42519. http://dx.doi.org/10.1074/jbc.M103013200.
54. Donai H, Murakami T, Amano T, Sogawa Y, Yamauchi T. 2000. Induction and alternative splicing of delta isoform of Ca(+_)/calmodulin-dependent protein kinase II during neural differentiation of P19 embryonal carcinoma cells and during brain development. Brain Res. Mol. Brain Res. 85:189-199. http://dx.doi.org/10.1016/S0169-328X(00)00221-7
55. Donai H, Nakamura M, Sogawa Y, Wang JK, Urushihara M, Yamauchi T. 2000. Involvement of Ca2+/calmodulin-dependent protein kinase II in neurite outgrowth induced by cAMP treatment and serum deprivation in a central nervous system cell line, CAD derived from rat brain. Neurosci. Lett. 293:111-114. http://dx.doi.org/10.1016/S0304-3940(00)01500-7
56. Johnson LD, Willoughby CA, Burke SH, Paik DS, Jenkins KJ, Tombes RM. 2000. delta Ca(2+)/calmodulin-dependent protein kinase II isozyme-specific induction of neurite outgrowth in P19 embryonal carcinoma cells. J. Neurochem. 75:2380-2391. http://dx.doi.org/10.1046/j.1471-4159.2000.0752380.x.
57. Kutcher LW, Beauman SR, Gruenstein EI, Kaetzel MA, Dedman JR. 2003. Nuclear CaMKII inhibits neuronal differentiation of PC12 cells without affecting MAPK or CREB activation. Am. J. Physiol. Cell Physiol. 284:C1334-C1345. http://dx.doi.org/10.1152/ajpcell.00510.2002
58. Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, Matsuda M, Coban C, Ishii KJ, Kawai T, Takeuchi O, Akira S. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J. Exp. Med. 201:915-923. http://dx.doi.org/10.1084/jem.20042372.